GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Inventories, Raw Materials & Components

TLTFF (Theralase Technologies) Inventories, Raw Materials & Components : $0.30 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Inventories, Raw Materials & Components?

Theralase Technologies's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $0.30 Mil.

Theralase Technologies's quarterly raw materials declined from Jun. 2024 ($0.32 Mil) to Sep. 2024 ($0.32 Mil) and declined from Sep. 2024 ($0.32 Mil) to Dec. 2024 ($0.30 Mil).

Theralase Technologies's annual raw materials increased from Dec. 2022 ($0.15 Mil) to Dec. 2023 ($0.37 Mil) but then declined from Dec. 2023 ($0.37 Mil) to Dec. 2024 ($0.30 Mil).


Theralase Technologies Inventories, Raw Materials & Components Historical Data

The historical data trend for Theralase Technologies's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Inventories, Raw Materials & Components Chart

Theralase Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.19 0.15 0.37 0.30

Theralase Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.37 0.32 0.32 0.30

Theralase Technologies Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Theralase Technologies Business Description

Traded in Other Exchanges
Address
41 Hollinger Road, Toronto, ON, CAN, M4B 3G4
Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The Device Division designs develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (FDA) for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions.